THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE

巨噬细胞衰老在调节眼部血管生成中的重要性

基本信息

  • 批准号:
    8139775
  • 负责人:
  • 金额:
    $ 32.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The macrophage is a key component of the innate arm of immunity and is critical in regulating initial immune response to tumors, infections and in inflammation. The macrophage is also a central player in sustaining immune privilege in the eye. Immunosenescence is characterized by age-related changes in both the innate and adaptive compartments of the immune system. Innate immunity, specifically macrophage function, has received particular attention in the eye as it can modulate developmental and post-developmental angiogenesis. Ocular neovascularization plays a central role in visual impairment and blindness in several disease states of the eye, including age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity, and intraocular tumors. The work described in this proposal will help elucidate the mechanisms by which senescence induces a functional drift in macrophages towards a deleterious pro-angiogenic phenotype. Our studies will also test how altering macrophage polarization determines angiogenic fate in the eye. These questions are especially relevant to the importance of macrophages in AMD. These goals will be accomplished by: a) Quantifying age-related changes in IL-10 activated signaling pathways in macrophages that lead to loss of anti-angiogenic function and b) Demonstrating that abnormal processing of cholesterol, a dominant component of drusen, causes old macrophages to become pro- angiogenic. Public Health Relevance: Angioproliferative eye diseases account for a significant majority of blindness burden across all age groups. Mechanisms that lead to immune dysfunction as identified in this proposal that are relevant to the pathophysiology of abnormal angiogenesis will help us devise immune based therapies that ameliorate disease progression and ultimately blindness. PUBLIC HEALTH RELEVANCE: Immune cells and cytokines secreted by immune cells, specifically macrophages, are emerging as central players in regulating eye diseases associated with abnormal blood vessel growth. These include age-related macular degeneration, retinopathy of prematurity, and diabetic retinopathy. We aim to understand the mechanisms by which macrophage dysfunction promotes disease progression and hope to provide new insights in order to design future therapies to prevent blindness from these diseases.
描述(申请人提供):巨噬细胞是天然免疫手臂的关键组成部分,在调节对肿瘤、感染和炎症的初始免疫反应中起关键作用。巨噬细胞在维持眼睛的免疫豁免权方面也是一个核心角色。免疫衰老的特征是免疫系统的先天和适应性两个部分的年龄相关变化。先天性免疫,特别是巨噬细胞的功能,在眼睛中受到特别的关注,因为它可以调节发育和发育后的血管生成。眼部新生血管在老年性黄斑变性、糖尿病视网膜病变、早产儿视网膜病变和眼内肿瘤等多种眼部疾病的视力损害和失明中起核心作用。这项建议中描述的工作将有助于阐明衰老导致巨噬细胞向有害的促血管生成表型的功能漂移的机制。我们的研究还将测试改变巨噬细胞极化如何决定眼睛中血管生成的命运。这些问题与巨噬细胞在AMD中的重要性尤其相关。这些目标将通过以下方式实现:a)量化IL-10激活的巨噬细胞中与年龄相关的导致抗血管生成功能丧失的信号通路的变化,以及b)证明胆固醇的异常处理导致老年巨噬细胞变得促进血管生成。公共卫生相关性:血管增生性眼病在所有年龄段的失明负担中占相当大的比例。这项建议中确定的导致免疫功能障碍的机制与异常血管生成的病理生理学相关,将有助于我们设计基于免疫的治疗方法,以缓解疾病的进展,并最终减轻失明。 与公共卫生相关:免疫细胞和免疫细胞分泌的细胞因子,特别是巨噬细胞,正在成为调节与异常血管生长相关的眼病的核心角色。这些疾病包括老年性黄斑变性、早产儿视网膜病变和糖尿病视网膜病变。我们的目标是了解巨噬细胞功能障碍促进疾病进展的机制,并希望提供新的见解,以便设计未来的治疗方法来预防这些疾病导致的失明。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAJENDRA S APTE其他文献

RAJENDRA S APTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAJENDRA S APTE', 18)}}的其他基金

THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    7883064
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
Macrophage miR146B and Ocular Neovascularization
巨噬细胞 miR146B 与眼部新生血管形成
  • 批准号:
    10231124
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    8733858
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
MACROPHAGE MIR146B AND OCULAR NEOVASCULARIZATION
巨噬细胞 MIR146B 和眼新生血管化
  • 批准号:
    10285203
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    8324049
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
Macrophage miR146B and Ocular Neovascularization
巨噬细胞 miR146B 与眼部新生血管形成
  • 批准号:
    10004649
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    8527781
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    8721422
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
Macrophage miR146B and Ocular Neovascularization
巨噬细胞 miR146B 与眼部新生血管形成
  • 批准号:
    9761526
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE
巨噬细胞衰老在调节眼部血管生成中的重要性
  • 批准号:
    8308562
  • 财政年份:
    2010
  • 资助金额:
    $ 32.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了